Fukang Yuan

760 total citations
27 papers, 637 citations indexed

About

Fukang Yuan is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Fukang Yuan has authored 27 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Surgery and 6 papers in Cancer Research. Recurrent topics in Fukang Yuan's work include Cancer-related molecular mechanisms research (4 papers), Nanoplatforms for cancer theranostics (4 papers) and MicroRNA in disease regulation (2 papers). Fukang Yuan is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), Nanoplatforms for cancer theranostics (4 papers) and MicroRNA in disease regulation (2 papers). Fukang Yuan collaborates with scholars based in China, Australia and United States. Fukang Yuan's co-authors include Jinbao Qin, Xinwu Lu, Kaichuang Ye, Bo Li, Xinrui Yang, Zhiyou Peng, Lijia Huang, Yuxin Zhang, Junqing Hu and Mier Jiang and has published in prestigious journals such as Advanced Functional Materials, Journal of Agricultural and Food Chemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Fukang Yuan

25 papers receiving 630 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fukang Yuan China 13 252 172 154 126 90 27 637
Gaia Zuccolotto Italy 16 201 0.8× 300 1.7× 72 0.5× 77 0.6× 141 1.6× 28 878
Tao Ying China 15 92 0.4× 188 1.1× 129 0.8× 56 0.4× 75 0.8× 95 778
Wei Fu China 16 242 1.0× 380 2.2× 144 0.9× 59 0.5× 48 0.5× 32 879
Hongcheng Shi China 16 405 1.6× 226 1.3× 145 0.9× 155 1.2× 111 1.2× 65 1.0k
Hoon Choi United States 11 206 0.8× 258 1.5× 93 0.6× 99 0.8× 64 0.7× 18 675
Anne‐Laure Papa United States 15 378 1.5× 137 0.8× 149 1.0× 208 1.7× 49 0.5× 21 852
Deborah Sultan United States 17 323 1.3× 189 1.1× 229 1.5× 141 1.1× 54 0.6× 28 903
Amanda M. Hamilton Canada 16 220 0.9× 242 1.4× 77 0.5× 124 1.0× 70 0.8× 37 749
Carla Tripisciano Austria 13 235 0.9× 358 2.1× 180 1.2× 46 0.4× 60 0.7× 27 760

Countries citing papers authored by Fukang Yuan

Since Specialization
Citations

This map shows the geographic impact of Fukang Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fukang Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fukang Yuan more than expected).

Fields of papers citing papers by Fukang Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fukang Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fukang Yuan. The network helps show where Fukang Yuan may publish in the future.

Co-authorship network of co-authors of Fukang Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Fukang Yuan. A scholar is included among the top collaborators of Fukang Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fukang Yuan. Fukang Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Zhenduo, Ying Liu, Ziqi Tao, et al.. (2025). Apigenin inhibits recurrent bladder cancer progression by targeting VEGF-β. Cancer Letters. 620. 217676–217676. 3 indexed citations
2.
Dai, Jun, Lingshan Gou, Ye Tian, et al.. (2024). Mechanistic Study of Purple Sweet Potato Anthocyanins: Multifaceted Anti-Fibrotic Effects and Targeting of PDGFRβ in Liver Fibrosis. Journal of Agricultural and Food Chemistry. 72(50). 27861–27875. 3 indexed citations
4.
Liu, Shiwei, et al.. (2024). PTGES3 proteolysis using the liposomal peptide-PROTAC approach. Biology Direct. 19(1). 144–144. 1 indexed citations
5.
Liu, Yiren, et al.. (2024). Stent Insertion for Inoperable Hilar Cholangiocarcinoma: Comparison Between Unilateral Radioactive Stent and Bilateral Normal Stent. Surgical Laparoscopy Endoscopy & Percutaneous Techniques. 34(2). 190–195. 1 indexed citations
6.
Yuan, Fukang, et al.. (2021). Thrombolysis Combined Therapy Using CuS@SiO2-PEG/uPA Nanoparticles. Frontiers in Chemistry. 9. 643411–643411. 12 indexed citations
7.
Yuan, Fukang, et al.. (2021). Radioactive Seed Strand Efficacy in Superior Vena Cava Stenting Due to Non-small-cell Lung Cancer Obstruction. Vascular and Endovascular Surgery. 56(2). 173–179. 1 indexed citations
8.
Yuan, Fukang, et al.. (2020). Endovascular treatment with stenting of celiac artery aneurysms. Medicine. 99(48). e23448–e23448. 3 indexed citations
9.
Liu, Yan, et al.. (2020). S-adenosylmethionine induces apoptosis and cycle arrest of gallbladder carcinoma cells by suppression of JAK2/STAT3 pathways. Naunyn-Schmiedeberg s Archives of Pharmacology. 393(12). 2507–2515. 7 indexed citations
10.
Li, Wenhua, Fukang Yuan, Xin Zhang, et al.. (2019). Elevated MIR100HG promotes colorectal cancer metastasis and is associated with poor prognosis. Oncology Letters. 18(6). 6483–6490. 17 indexed citations
11.
Shi, Xi, Wei Zhuang, Shi‐Li Zhang, et al.. (2018). Follicle-stimulating hormone inhibits cervical cancer via NF-κB pathway. OncoTargets and Therapy. Volume 11. 8107–8115. 6 indexed citations
12.
Zeng, Hong, et al.. (2018). As an independent prognostic factor, USP6 promotes the invasion and metastasis of colon cancer. Biochemical and Biophysical Research Communications. 505(3). 816–822. 12 indexed citations
13.
Li, Bo, Fukang Yuan, Guanjie He, et al.. (2017). Ultrasmall CuCo2S4 Nanocrystals: All‐in‐One Theragnosis Nanoplatform with Magnetic Resonance/Near‐Infrared Imaging for Efficiently Photothermal Therapy of Tumors. Advanced Functional Materials. 27(10). 111 indexed citations
14.
Liu, Xianwu, Bin Quan, Hui Wang, et al.. (2017). Elevated expression of KLK8 predicts poor prognosis in colorectal cancer. Biomedicine & Pharmacotherapy. 88. 595–602. 19 indexed citations
15.
Qin, Jinbao, Zhen Zhao, Ruihua Wang, et al.. (2017). In Situ Laser Fenestration Is a Feasible Method for Revascularization of Aortic Arch During Thoracic Endovascular Aortic Repair. Journal of the American Heart Association. 6(4). 85 indexed citations
16.
Qin, Jinbao, Fukang Yuan, Zhiyou Peng, et al.. (2015). Periostin enhances adipose-derived stem cell adhesion, migration, and therapeutic efficiency in Apo E deficient mice with hind limb ischemia. Stem Cell Research & Therapy. 6(1). 138–138. 26 indexed citations
17.
Peng, Zhiyou, Jinbao Qin, Bo Li, et al.. (2015). An effective approach to reduce inflammation and stenosis in carotid artery: polypyrrole nanoparticle-based photothermal therapy. Nanoscale. 7(17). 7682–7691. 29 indexed citations
18.
Lu, Xinwu, Jinbao Qin, Peng Chen, et al.. (2014). Noninvasive detection of macrophages in atherosclerotic lesions by computed tomography enhanced with PEGylated gold nanoparticles. International Journal of Nanomedicine. 9. 5575–5575. 23 indexed citations
19.
Yuan, Fukang, et al.. (2014). Improvement in the repair of defects in maxillofacial soft tissue in irradiated minipigs by a mixture of adipose-derived stem cells and platelet-rich fibrin. British Journal of Oral and Maxillofacial Surgery. 52(8). 740–745. 24 indexed citations
20.
Ye, Kaichuang, Jinbao Qin, Zhiyou Peng, et al.. (2014). Polyethylene glycol-modified dendrimer-entrapped gold nanoparticles enhance CT imaging of blood pool in atherosclerotic mice. Nanoscale Research Letters. 9(1). 529–529. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026